Provided by Tiger Trade Technology Pte. Ltd.

VistaGen Therapeutics

0.2400
+0.00642.74%
Post-market: 0.24010.0001+0.04%19:59 EDT
Volume:718.61K
Turnover:175.61K
Market Cap:10.65M
PE:-0.14
High:0.2532
Open:0.2340
Low:0.2340
Close:0.2336
52wk High:5.14
52wk Low:0.1980
Shares:44.38M
Float Shares:41.42M
Volume Ratio:2.16
T/O Rate:1.73%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.6559
EPS(LYR):-1.8303
ROE:-166.46%
ROA:-83.21%
PB:0.44
PE(LYR):-0.13

Loading ...

Aug 17, 2022

Major Issues Report

8-K - Current report
Aug 12, 2022

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Aug 11, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 11, 2022

Major Issues Report

8-K - Current report
Jul 22, 2022

Major Issues Report

8-K - Current report
Jul 08, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jun 23, 2022

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Jun 23, 2022

Major Issues Report

8-K - Current report
Jun 22, 2022

Major Issues Report

8-K - Current report
Jun 09, 2022

Major Issues Report

8-K - Current report
May 06, 2022

Major Issues Report

8-K - Current report
May 03, 2022

Major Issues Report

8-K - Current report
Apr 22, 2022

Major Issues Report

8-K - Current report
Apr 14, 2022

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Apr 13, 2022

Major Issues Report

8-K - Current report
Feb 15, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 11, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 10, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Feb 10, 2022

Major Issues Report

8-K - Current report